Biotie Therapies - Changes board/management/auditors

New interim CFO in Biotie

BIOTIE THERAPIES CORP.         STOCK EXCHANGE RELEASE   1 September 2011 at 1
p.m.

New interim CFO in Biotie

Biotie's interim Chief Financial Officer Ulla Sjöblom will be leaving the
company to pursue other interests. Zack McNealy, Vice President, Finance of the
group's US subsidiary will assume the role of acting Chief Financial Officer
starting September 1, 2011. The Company expects to conclude the ongoing CFO
search process by the end of this year.

Zack McNealy has been Vice President, Finance of Biotie Therapies, Inc.
(formerly Synosia Therapeutics) since 2007. Before this, he served as a Plant
Controller, Finance Manager, and Financial Analyst with Johnson & Johnson from
1997-2006.

Turku, 1 September 2011

Biotie Therapies Corp.

Timo Veromaa
President and CEO

For further information, please contact:

Virve Nurmi, Biotie Therapies Corp.
tel. +358 2 274 8900
e-mail: virve.nurmi@biotie.com

DISTRIBUTION
NASDAQ OMX Helsinki Ltd
Main Media
www.biotie.com


[HUG#1543410]